Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan-Reference-Cited by-同舟云学术

Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan

Published:2012-02-14 Issue:2 Volume:13 Page:239-243
ISSN:1470-3203
Container-title:Journal of the Renin-Angiotensin-Aldosterone System
language:en
Short-container-title:J Renin Angiotensin Aldosterone Syst

Author:

Ono Minamo¹,Fukuda Michio¹,Miura Toshiyuki¹,Mizuno Masashi¹,Kato Yoko¹,Sato Ryo¹,Naito Takehiro¹,Togawa Hiroyuki¹,Sasakawa Yuji¹,Tomonari Tatsuya¹,Ichikawa Tadashi¹,Shirasawa Yuichi¹,Ito Akinori¹,Yoshida Atsuhiro¹,Kimura Genjiro¹

Affiliation:

1. Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Japan

Publisher

Hindawi Limited

Subject

Endocrinology,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1470320311434817

Reference30 articles.

1. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy

2. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis

3. Crucial role of kidney function in resistance to antihypertensive therapy in patients with diabetes mellitus

4. Antihypertensive and antiproteinuric efficacy of ramiprilin children with chronic renal failure

5. Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mathematical modeling of antihypertensive therapy;Frontiers in Physiology;2022-12-14

2. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats;European Journal of Pharmacology;2014-12

3. New Insight into the Molecular Drug Target of Diabetic Nephropathy;International Journal of Endocrinology;2014

4. Identification of the Stages of Diabetic Nephropathy at Which Angiotensin II Receptor Blockers Most Effectively Suppress Albuminuria;American Journal of Hypertension;2013-06-17

5. Angiotensin receptor blockers regulate the synchronization of circadian rhythms in heart rate and blood pressure;Journal of Hypertension;2013-06